Three Years Forgotten, Why Go Crazy When I Say Goodbye? novel Chapter 428

In the realm of genetic research, theoretical knowledge was utterly useless without raw, clinical data. And recently, Professor Smith had stumbled upon a once-in-a-lifetime opportunity.

Late that evening, the harsh, sterile glow of the lab's surgical lights illuminated stacks of international journals and genomic sequencing reports. The faint, clinical scent of disinfectant mixed with the crisp smell of printed paper hung heavy in the air.

Professor Smith stared at a freshly updated global rare disease database report, his eyes clouded with a torturous mix of awe and frustration.

Having dedicated his life to gene editing, his holy grail wasn't just textbook theory—it was real-world clinical anomalies and live tissue samples. Any opportunity to study an extreme mutation in the field held unimaginable, paradigm-shifting value.

Unfortunately, this specific case was a logistical nightmare.

The patient was suffering from a staggeringly rare, complex genetic mutation causing severe skin degeneration. It was an ultra-rare subtype of Epidermolysis Bullosa. There were only three documented cases left on the planet, and this particular patient presented the most stable survival rate and the most comprehensive progression of the disease. The scientific value was astronomical.

Unlike standard single-gene disorders, this patient's mutation points were impossibly hidden, triggering a dual collapse of both epidermal and interstitial repair genes. It was an anomaly that standard lab simulations and mouse models could never accurately replicate.

To any geneticist, this was a divine gift. It was the key to a monumental breakthrough that would cement their legacy. Smith should have been ecstatic, but instead, he was overwhelmed with anxiety. This golden opportunity came with a seemingly insurmountable barrier.

The patient was young Maya. Her family kept her fiercely protected in the Appalachian Highlands. The region was a geographical fortress—no direct flights, no nearby train stations. The final stretch required navigating dozens of miles of treacherous, unpaved mountain ridges, making it nearly impossible for a standard research team to transport highly sensitive medical equipment. Moreover, the local community was intensely insular and conservative, fiercely rejecting outsiders, especially medical professionals. Two separate domestic research teams had already attempted the journey, only to be chased out before they even caught a glimpse of the family, let alone gathered any viable data.

Smith looked instantly skeptical.

Jayden pressed his advantage. "Our primary roadblocks are funding the logistics and navigating the hostile local environment."

"On the first point, Vivienne represents the Sinclair Group. She has unlimited access to capital, off-road fleets, and logistical support. This expedition requires portable sequencing rigs, sterile sampling units, a dedicated security detail, and a convoy of heavy-duty SUVs to handle those mountain roads. She can personally finance and coordinate the entire operation. It wouldn't cost our grant a single dime, and you wouldn't have to lift a finger to organize it."

"As for the local resistance, Vivienne is a New York socialite. She thrives on networking, maneuvering through complex social webs, and bribing the right people to open locked doors. Where a team of straightforward academics would fail, she might actually have the ruthless charm required to buy our way in."